#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Sclerotherapy is a minimally invasive, image-guided treatment that involves injecting a liquid medication into a vascular malformation to shrink and close it.
Sclerotherapy is most commonly used to treat vascular malformations (venous, lymphatic and arteriovenous). These are abnormal blood vessels or fluid-filled channels that can appear anywhere in the body and cause pain, swelling or other symptoms.
Sclerotherapy shrinks and closes vascular malformations by injecting them with a medication called a sclerosant. The sclerosant irritates the inside of the malformation, making it swell and close over time. Repeat procedures may be needed to close the malformation completely.
At Boston Children’s, the specialists in our Interventional Radiology Department are all experienced in performing sclerotherapy on infants and children.
Our team includes interventional radiologists, neurointerventional radiologists, anesthesiologists, nurse practitioners, nurses and technologists.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”